US Stock MarketDetailed Quotes

MNKD MannKind

Watchlist
  • 5.420
  • -0.130-2.34%
Close Feb 14 16:00 ET
1.49BMarket Cap67.75P/E (TTM)

About MannKind Company

MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Danbury, CT.

Company Profile

SymbolMNKD
Company NameMannKind
Listing DateJul 28, 2004
Issue Price14.00
Founded1991
CEOMr. Michael E. Castagna, Pharm.D.
MarketNASDAQ
Employees414
Fiscal Year Ends12-31
Address1 Casper Street
CityDanbury
ProvinceConnecticut
CountryUnited States of America
Zip Code06810
Phone1-818-661-5000
Websitehttp://www.mannkindcorp.com

Company Executives

  • Name
  • Position
  • Salary
  • Michael E. Castagna, Pharm.D.
  • Director and Chief Executive Officer
  • 7.07M
  • Stuart A. Tross, PhD
  • Executive Vice President, Chief People and Workplace Officer
  • 2.22M
  • Christopher B. Prentiss
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Dr. Burkhard Blank,M.D.
  • Executive Vice President, Research and Development and Chief Medical Officer
  • --
  • Dr. David B. Thon, J.D.
  • Executive Vice President, General Counsel and Secretary
  • 2.34M
  • Lauren M. Sabella
  • Executive Vice President, Operations
  • 1.91M
  • Sanjay R. Singh
  • Executive Vice President, Technical Operations
  • --
  • Dr. James S. Shannon, M.D.,M.R.C.P.
  • Chairman of the Board
  • 255.64K
  • Steven B. Binder
  • Director
  • 2.34M
  • Jennifer Grancio
  • Independent Director
  • 221.73K
  • Dr. Michael A. Friedman M.D.
  • Independent Director
  • 229.23K
  • Christine A. Mundkur
  • Independent Director
  • 226.73K
  • Ronald J. Consiglio
  • Independent Director
  • 241.73K
  • Anthony C. Hooper
  • Independent Director
  • 233.14K
  • Sabrina Kay
  • Independent Director
  • 221.73K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
HENDERA
831152
+30.00%
Hengerda New Materials
300946
+20.01%
Fujian Nebula Electronics.,Ltd
300648
+20.00%
4
Cubic Digital Technology
300344
+19.98%
5
HNAC Technology
300490
+19.95%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio? Show More
FOMC Press Conference, January 29, 2025
Monetary Policy: Navigating the Fed's Rate Cut Cycle
Changing Fed policy is altering the market math for investors.